Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Rabaud

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Infectious Diseases Now|July 11, 2022
Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 seasonDavid Luque-Paz, Emmanuel Orhant, Fabrice Michel, et al.
Pain|December 6, 2011
Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practiceDidier Bouhassira, Olivier Chassany, Jacques Gaillat, et al.
AIDS (London, England)|August 24, 2010
Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulationWilliam Tosini, Philippe Muller, Thierry Prazuck, et al.
AIDS Patient Care and Stds|January 26, 2010
Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIVChristine Burty, Thierry Prazuck, Francois Truchetet, et al.
Microorganisms|August 7, 2021
Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme BorreliosisAlice Raffetin, Aude Barquin, Steve Nguala, et al.
Journal of Clinical Microbiology|September 10, 2010
Gluconobacter as well as Asaia species, newly emerging opportunistic human pathogens among acetic acid bacteriaCorentine Alauzet, Corinne Teyssier, Estelle Jumas-Bilak, et al.
Lancet (London, England)|September 16, 2016
Hepatitis C: the path towards effective universal therapyLionel Piroth, Christian Rabaud, David Rey, et al.
Scandinavian Journal of Infectious Diseases|November 20, 2009
Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective studyLionel Piroth, André Pechinot, Anne Minello, et al.
AIDS and Behavior|February 25, 2016
Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE CohortMarie Préau, Vanessa Laguette, Laura March, et al.
AIDS (London, England)|January 2, 2007
Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimenSimona Pavel, Christine Burty, Isabelle Alcaraz, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Infectious Diseases Now|July 11, 2022
Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 seasonDavid Luque-Paz, Emmanuel Orhant, Fabrice Michel, et al.
Pain|December 6, 2011
Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practiceDidier Bouhassira, Olivier Chassany, Jacques Gaillat, et al.
AIDS (London, England)|August 24, 2010
Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulationWilliam Tosini, Philippe Muller, Thierry Prazuck, et al.
AIDS Patient Care and Stds|January 26, 2010
Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIVChristine Burty, Thierry Prazuck, Francois Truchetet, et al.
Microorganisms|August 7, 2021
Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme BorreliosisAlice Raffetin, Aude Barquin, Steve Nguala, et al.
Journal of Clinical Microbiology|September 10, 2010
Gluconobacter as well as Asaia species, newly emerging opportunistic human pathogens among acetic acid bacteriaCorentine Alauzet, Corinne Teyssier, Estelle Jumas-Bilak, et al.
Lancet (London, England)|September 16, 2016
Hepatitis C: the path towards effective universal therapyLionel Piroth, Christian Rabaud, David Rey, et al.
Scandinavian Journal of Infectious Diseases|November 20, 2009
Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective studyLionel Piroth, André Pechinot, Anne Minello, et al.
AIDS and Behavior|February 25, 2016
Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE CohortMarie Préau, Vanessa Laguette, Laura March, et al.
AIDS (London, England)|January 2, 2007
Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimenSimona Pavel, Christine Burty, Isabelle Alcaraz, et al.
Pageof 6